However, ozanimod treatment can be continued during an active COVID-19 infection at the physician’s discretion. Patients with a history of diabetes, uveitis, or macular edema should have regular ...

Overall, 736 patients went from interferon β-1a 30 μg to ozanimod 0.92 mg, 877 from 0.46 mg to 0.92 mg ozanimod, and 881 stayed on 0.92 mg ozanimod.

New Data Presented at the American College of Gastroenterology Annual Scientific Meeting Demonstrate Continuous Zeposia (ozanimod) Treatment Prevents Disease Relapse Over One Year in 86.1% of ...

ORLANDO -- Women with inflammatory bowel disease or relapsing multiple sclerosis who became pregnant while taking the sphingosine-1-phosphate (S1P) receptor modulator ozanimod (Zeposia) did not ...

Meeting Coverage > ACTRIMS Ozanimod Controls MS Disease Activity Regardless of Age — Clinical, radiologic measures remained stable or improved in both younger and older patients by Ed Susman ...

Among those with CDP, 44.3% and 54.5% of those treated with continuous ozanimod had either RAW or PIRA, 8% had both, while 57.8% and 43.4% of participants who switched from IFN to ozanimod had RAW ...

Ozanimod works by restricting lymphocytes (an immune system cell) from leaving the lymph nodes. The way Zeposia works in the body for UC is not fully known, but it is thought to be related to the ...

SUMMIT, N.J.-- (BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced that its phase III SUNBEAM trial, evaluating the efficacy and safety of ozanimod, an investigational oral ...

This approval designates Velsipity (etrasimod) as only the second S1P receptor modulator available for the treatment of UC since Zeposia (Ozanimod, Bristol Myers Squibb) was approved for the ...